Genetic analysis showed 22.4% patients have NUDT15 polymorphisms, 10.3% patients have TPMT polymorphisms, 13.7% patients have TEL / AML1, 3.4% patients have BCR - ABL, 3.4% patients have E2A / PBX1 and 1.7% patient have MLL/AF4.